Clostridioides difficile (C. difficile) is progressively colonizing humans and animals living
with humans. During this process, hypervirulent strains and mutated toxin A and B of C …

Clostridioides difficile infection (CDI) has a serious impact on the healthcare system, and
most of its pathogenic effects are mainly due to the activity of toxins A and B (TcdA and TcdB …

Clostridioides difficile infection (CDI) represents an important health problem worldwide,
with significant morbidity and mortality. This infection has also high recurrence rates, whose …

Colonization with toxigenic Clostridium difficile may be associated with a wide spectrum of
clinical presentation ranging from asymptomatic carriage to mild diarrhea to life-threatening …

Bacterial infections are characterized by an inflammatory response, which is essential for
infection containment but is also responsible for negative effects on the host. The pathogen …

Background Clostridium difficile infection (CDI) affects patients with inflammatory bowel
disease (IBD). The aim of this study was to compare humoral response to C. difficile toxins in …

Clostridioides difficile infection is widespread throughout countries and represents an
important cause of nosocomial diarrhoea, with relatively high morbidity. This infection often …

Clostridioides difficile (C. difficile) represents a major health burden with substantial
economic and clinical impact. Patients with inflammatory bowel diseases (IBD) were …

Clostridioides difficile infection (CDI) is the leading cause of nosocomial antibiotic-
associated diarrhea, and colitis, with increasing incidence and healthcare costs. Its …

Clostridium difficile (C. difficile) is the most common cause of nosocomial antibiotic-
associated diarrhea and the etiologic agent of pseudomembranous colitis. The clinical …